Emisphere Technologies, Inc.
Sep 2, 2015

Emisphere to Present at Rodman and Renshaw 17th Annual Global Investment Conference

ROSELAND, N.J., Sept. 2, 2015 (GLOBE NEWSWIRE) -- Emisphere Technologies, Inc. (OTCBB:EMIS) today announced that President and Chief Executive Officer, Alan L. Rubino, will present at the Rodman and Renshaw 17th Annual Global Investment Conference at 9:35 AM ET on Wednesday, September 9, 2015. The Rodman and Renshaw conference is being held at The St. Regis Hotel in New York City.

Emisphere's presentation will be webcast live the day of the Rodman and Renshaw conference, and will be available on the company's website at http://ir.emisphere.com/events.cfm. An archive of the webcast will be available for 90 days following the day of the conference and can be accessed by following the same link.

About Emisphere

Emisphere is a specialty pharmaceutical company that has recently commenced commercial operations. The Company launched its first prescription product, oral Eligen B12, in the U.S. in March 2015. Beyond Eligen B12, the Company utilizes its proprietary Eligen® Technology to create new oral formulations of therapeutic agents. Emisphere is currently partnered with global pharmaceutical companies for the development of new, orally delivered therapeutics. For more information, please visit www.emisphere.com.

CONTACT: COMPANY CONTACTS:



         Alan L. Rubino, CEO

         973.532.8000

         arubino@emisphere.com



         Michael R. Garone, CFO

         973.532.8005

         mgarone@emisphere.com



         INVESTOR CONTACTS:



         Susan Kim

         Argot Partners

         (212) 600-1902

         susan@argotpartners.com

Emisphere Technologies, Inc. Logo

Source: Emisphere Technologies, Inc.

News Provided by Acquire Media